Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Pierre-Luc Etienne"'
Autor:
Nicolas Giraud, Olivier Saut, Thomas Aparicio, Philippe Ronchin, Louis-Arnaud Bazire, Emilie Barbier, Claire Lemanski, Xavier Mirabel, Pierre-Luc Etienne, Astrid Lièvre, Wulfran Cacheux, Ariane Darut-Jouve, Christelle De la Fouchardière, Arnaud Hocquelet, Hervé Trillaud, Thomas Charleux, Gilles Breysacher, Delphine Argo-Leignel, Alexandre Tessier, Nicolas Magné, Meher Ben Abdelghani, Côme Lepage, Véronique Vendrely
Publikováno v:
Cancers, Vol 13, Iss 2, p 193 (2021)
Purpose: Chemo-radiotherapy (CRT) is the standard treatment for non-metastatic anal squamous cell carcinomas (ASCC). Despite excellent results for T1-2 stages, relapses still occur in around 35% of locally advanced tumors. Recent strategies focus on
Externí odkaz:
https://doaj.org/article/d2d10450729c4e37b9fad33336e63e86
Autor:
Julie Niogret, Emeric Limagne, Marion Thibaudin, Julie Blanc, Aurelie Bertaut, Karine Le Malicot, Yves Rinaldi, François-Xavier Caroli-Bosc, Franck Audemar, Suzanne Nguyen, Corinne Sarda, Catherine Lombard-Bohas, Christophe Locher, Miguel Carreiro, Jean-Louis Legoux, Pierre-Luc Etienne, Mathieu Baconnier, Marc Porneuf, Thomas Aparicio, Francois Ghiringhelli
Publikováno v:
Cancers, Vol 12, Iss 6, p 1429 (2020)
Background: Predictive biomarkers of response to chemotherapy plus antiangiogenic for metastatic colorectal cancer (mCRC) are lacking. The objective of this study was to test the prognostic role of splenomegaly on baseline CT scan. Methods: This stud
Externí odkaz:
https://doaj.org/article/ed11c69328b84cc1be1a20b77ad5eadb
Autor:
Caroline Bascoul-Mollevi, Sophie Gourgou, Christophe Borg, Pierre-Luc Etienne, Emmanuel Rio, Eric Rullier, Beata Juzyna, Florence Castan, Thierry Conroy
Publikováno v:
European Journal of Cancer. 186:151-165
Autor:
Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez-Nebout, Véronique Vendrely, Xavier Artignan, Olivier Bouché, Dany Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Najib Lamfichekh, Béata Juzyna, Claire Jouffroy-Zeller, Eric Rullier, Frédéric Marchal, Sophie Gourgou, Florence Castan, Christophe Borg, Philippe Ronchin, Jean-François Seitz, Stéphane Corbinais, Emmanuel Maillard, Monique Noirclerc, Farid El Hajbi, Anne-Laure Villing, Yves Bécouarn, Lam Foong Fat Lam Kam Sang, Pascal Artru, Jean-Baptiste Bachet, Fayçal Hocine, Catherine Ligeza-Poisson, Claire Vautravers, Meher Ben Abdelghani, Thomas Aparicio, Elise Desot, Isabelle Marquis
Publikováno v:
The Lancet Oncology. 22:702-715
Summary Background Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery, and adjuvant chemotherapy controls local disease, but distant metastases remain common. We aimed to assess whether administering neoadjuvant chemotherapy
Autor:
David Malka, Benoît Dupont, Alain Gratet, Pamela Biondiani, Marion Chauvenet, Dany Gargot, Pierre-Emmanuel Henneresse, Hortense Laharie, Johann Dreanic, Valérie Lebrun Lyat, Catherine Brezault-Bonnet, Morgan Andre, Géraldine Perkins, Philippe Houyau, Yves Rinaldi, Etienne Suc, Dominique Besson, Valérie Boige, Cécile Julien, Julien Taieb, Simon Pernot, Benoît Avisse, Pauline Regnault, Ahmed Bedjaoui, Marie-Pierre Galais, Côme Lepage, Céline Lepère, Mme E. Barbier, Antoine Holllebecque, Anne Escande, Julie Vincent, Sandrine Lavau denes, Marie-Claude Gouttebel, Leila Bengrine Lefevre, Anne Thirot Bidault, Anne-Laure Pointet, Julie Gigout, Faiza Khemissa Akouz, Louis-Marie Dourthe, Frederick Moryoussef, Maxime Lesouef, Vincent Bourgeois, François Ghiringhelli, Patrick Texereau, Samy Louafi, Gildas Phelip, Yann Berge, Jean-François Codoul, Jérôme Chamois, Eric Terrebonne, Karine Bouhier Leporrier, Bidaut Wahiba, X. Artignan, Pr Pierre Michel, Iulia Pripon, David Sefrioui, Pierre-Luc Etienne, Romain Coriat, Aurélie Parzy, Mustapha Atlassi, Aziz Zaanan, Jean-Baptiste Bachet, Philippe Dominici, Jean Martin, Mathilde Martinez, Dominique Genet, Raymond Despax, Karine Le Malicot, Laurent Miglianico, Salvatore Caruso, Bruno Valenza, Nicolas Barriere, Oana Zveltlana Cojocarasu
Publikováno v:
European Journal of Cancer. 136:25-34
Background Chemotherapy is effective in metastatic pancreatic adenocarcinoma (mPA), but new approaches are still needed to improve patients' survival and quality of life. We have previously published good efficacy and tolerability results on a sequen
Autor:
Guillaume Cadiot, Denis Smith, Thierry Nguyen-Tan-Hon, Brigitte Delemer, F Schillo, Bénédicte Decoudier, Pierre-Luc Etienne, Romain Coriat, Alexandre Santos, Isabelle Raingeard, Ségolène Bisot-Locard, Iradj Sobhani, Gérald Raverot
Publikováno v:
Advances in Therapy. 37:3901-3915
The first long-acting release (LAR) formulation of octreotide was marketed in France in the late 1990s. An injectable formulation of Sandostatin LAR® (Novartis SAS) with a new diluent has been developed to facilitate its preparation and administrati
Autor:
Eric Terrebonne, Hedia Brixi, Bernard Paule, Karine Le Malicot, Côme Lepage, Jean-Louis Legoux, Abakar Mahamat-Abakar, Thierry Lecomte, Pierre-Luc Etienne, Catherine Lombard-Bohas, Gabriel Choukroun, Sophie Dominguez, Philippe Ruszniewski, Pierre Michel, François-Xavier Caroli-Bosc, for Streptotox-FFCD investigators, Laetitia Dahan
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (5), pp.101572. ⟨10.1016/j.clinre.2020.10.014⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2021, 45 (5), pp.101572. ⟨10.1016/j.clinre.2020.10.014⟩
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (5), pp.101572. ⟨10.1016/j.clinre.2020.10.014⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2021, 45 (5), pp.101572. ⟨10.1016/j.clinre.2020.10.014⟩
Introduction Streptozocin can impair renal function. The purpose of this study was to evaluate the evolution of renal function in patients receiving this anti-mitotic for the treatment of locally advanced/metastatic digestive well differentiated neur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4ef5251bf40921ddc568e32623a457
https://univ-angers.hal.science/hal-03284389
https://univ-angers.hal.science/hal-03284389
Autor:
Antoine Adenis, François Ghiringhelli, Ludovic Gauthier, Thibault Mazard, Ludovic Evesque, Pierre-Luc Etienne, Alexandre Evrard, Patrick Chalbos, Jean-Pierre Bleuse, Diego Tosi, Sophie Gourgou, Marc Ychou
Publikováno v:
Journal of Clinical Oncology. 40:3561-3561
3561 Background: Standard treatment options for RAS-mutated mCRC pts include the combination of bevacizumab with FOLFIRINOX, a three-drug chemotherapy regimen. Unlike bevacizumab, REGO – an oral multi-tyrosine kinase agent - exhibits not only antia
Autor:
Benoist Chibaudel, Louis-Marie Dourthe, Thierry Andre, Julie Henriques, Vincent Bourgeois, Pierre-Luc Etienne, Jérôme Desrame, Elisabeth Carola, Olivier Dupuis, Nabil Baba-Hamed, Dominique Auby, Christophe Louvet, Emmanuel Maillard, Olivier Romano, Christophe Tournigand, Marie-Line Garcia-Larnicol, Einat Shacham Shmueli, Brian Healey Bird, François Ghiringhelli, Aimery De Gramont
Publikováno v:
Journal of Clinical Oncology. 40:3504-3504
3504 Background: The management of unresectable metastatic colorectal cancer (mCRC) is a comprehensive treatment strategy involving several lines of therapy, maintenance, salvage surgery, and treatment-free intervals. Besides chemotherapy (fluoropyri
Autor:
Christelle De La Fouchardiere, Arnaud Hocquelet, Véronique Vendrely, Emilie Barbier, Louis-Arnaud Bazire, Thomas Charleux, Meher Ben Abdelghani, Xavier Mirabel, Ariane Darut-Jouve, Wulfran Cacheux, Thomas Aparicio, Delphine Argo-Leignel, Nicolas Giraud, Pierre-Luc Etienne, Nicolas Magné, Hervé Trillaud, Olivier Saut, Gilles Breysacher, Philippe Ronchin, Alexandre Tessier, Claire Lemanski, Côme Lepage, Astrid Lièvre
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (2), pp.193. ⟨10.3390/cancers13020193⟩
Cancers, 2021, 13 (2), pp.193. ⟨10.3390/cancers13020193⟩
Cancers, Vol 13, Iss 193, p 193 (2021)
Volume 13
Issue 2
Cancers, MDPI, 2021, 13 (2), pp.193. ⟨10.3390/cancers13020193⟩
Cancers, 2021, 13 (2), pp.193. ⟨10.3390/cancers13020193⟩
Cancers, Vol 13, Iss 193, p 193 (2021)
Volume 13
Issue 2
Simple Summary Exclusive chemo-radiotherapy (CRT) is the standard treatment for non-metastatic anal squamous cell carcinomas. Identifying novel prognostic factors could help to improve CRT outcomes, notably for locally advanced diseases where relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4522a0462959a4f32b96628f4866692
https://hal.inria.fr/hal-03428535
https://hal.inria.fr/hal-03428535